Evidence map›Paper›PMID 33790538›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2021

Iberoamerican Ophthalmologists IOL Selection for Use on Themselves: Survey Results.

Daniel Scorsetti, Eduardo Viteri, Eduardo Mayorga

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Daniel ScorsettiScorsetti Institute, Buenos Aires, Argentina.
Eduardo ViteriHumana Vision Ophthalmological Center, Guayaquil, Ecuador.ORCID 0000-0001-7670-4600
Eduardo MayorgaEye Department, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0001-9864-0249
Hospital Italiano de Buenos Aires · ARUniversidad del Salvador · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine the preferred type of intraocular lens (IOL) that ophthalmologists would choose for themselves in case of cataract surgery.

designProspective convenience questionnaire study. MATERIALS AND

methodsWe developed an electronic survey with seven (7) questions, combining multiple and open options. The following categories were established: monofocal (MonoIOL) without monovision (MonoIOL-SM) and with monovision (MonoIOL-CM) and multifocal (MultiIOL) that could be either a bifocal (MultiIOL-B), trifocal (MultiIOL-T) or extended focus (MultiIOL-E). The link for the survey was sent to ophthalmologists from Latin America and Spain through different ways. The 1209 responses were analyzed statistically.

resultsWe received 1209 responses from 14 countries. The average age was 47.977 years (SD 11.711 years). Gender distribution was 839 males (72.8%) and 313 females (27.2%). Overall preference was MonoIOL-SM 23.90% (289), MonoIOL-CM 12.16% (147), MultiIOL-B 4.63% (56), MultiIOL-T 34.99% (423), MultiIOL-E 15.22% (110), and unsure 9.10% (110). Ophthalmologists that implant IOLs showed a greater preference for MultiIOL (64%) than those who did not implant IOLs (32.3%). Although all ophthalmologists preferred MultiIOL, anterior segment specialists chose them more frequently (59.1%) than posterior segment specialists (41%).

conclusionOphthalmologists would prefer to receive a multifocal IOL implantation despite the lower frequency of multifocal IOL implantation observed in the general population. The frequency was greater among ophthalmologists who implant IOLs compared to those who do not implant them. It was also greater among those who identified themselves as anterior segment specialists compared to posterior segment specialists.

Indexed as

cataract surgeryIOL typeophthalmologists

Identifiers

PMID33790538
PMCPMC8006974
OpenAlexW3136254937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.